<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03366818</url>
  </required_header>
  <id_info>
    <org_study_id>NEURO0001</org_study_id>
    <nct_id>NCT03366818</nct_id>
  </id_info>
  <brief_title>New Stent Retriever, VERSI System for AIS</brief_title>
  <official_title>Efficacy and Safety of VERSI System for Acute Ischemic Stroke</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kobe City General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kobe City General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To confirm efficacy and safety of VERSI system for acute ischemic stroke
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Efficacy; TICI 2a or more recanalization upto 3 pass of study device Safety; symptomatic
      intracranial hemorrhage within 24 hours of procedure
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">September 21, 2017</start_date>
  <completion_date type="Anticipated">April 30, 2018</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Device Feasibility</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>incidence of treatment-related severe adverse event</measure>
    <time_frame>within 24 hours after procedure</time_frame>
    <description>symptomatic intracranial hemorrhage</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>recovery to independent life {modified Rankin score of 2 or less]</measure>
    <time_frame>90days after procedure</time_frame>
    <description>Proportion of subjects who have modified Rankin Scale (mRS) score of 2 or less</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>all intracralnial hemorrhage</measure>
    <time_frame>within 24 hours after procedure</time_frame>
    <description>incidence of symptomatic and asymptomatic intracranial hemorrhage</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>acceptable clinical outcome</measure>
    <time_frame>90days after procedure</time_frame>
    <description>Proportion of subjects who have modified Rankin Scale (mRS) score of 2 or less or back to baseline of mRS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Severe adverse event related to device</measure>
    <time_frame>within 24 hours after procedure</time_frame>
    <description>Any severe adverse event related to device</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>recanalization ability of device</measure>
    <time_frame>immediatry after procedure</time_frame>
    <description>rate of immediate reperfusion with the device upto 3 path measured using Thrombolysis in Cerebrovascular Infarction (TICI) score of 2b or greater</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Acute Ischemic Stroke</condition>
  <arm_group>
    <arm_group_label>thrombectomy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>thrombectomy by Versi system</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>thrombectomy</intervention_name>
    <description>mechanical thrombectomy</description>
    <arm_group_label>thrombectomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  onset to treat within 8 hours

          -  NIHSS 8 or more

          -  ASPECTS 5 or more

          -  Target vessel is ICA, MCA, VA, BA, PCA

          -  non-eligible or failed IV rt-PA

        Exclusion Criteria:

          -  known hemorrhagic tendency

          -  arterial dissection, vasculitis

          -  allergy for contrast media

          -  other inappropriate condition
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nobuyuki Sakai, MD DMSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kobe City Medical Center General Hospital, Kobe, Japan</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kobe City General Hospital</name>
      <address>
        <city>Kobe</city>
        <state>Hyogo</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 11, 2017</study_first_submitted>
  <study_first_submitted_qc>December 6, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 8, 2017</study_first_posted>
  <last_update_submitted>December 6, 2017</last_update_submitted>
  <last_update_submitted_qc>December 6, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 8, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kobe City General Hospital</investigator_affiliation>
    <investigator_full_name>Nobuyuki Sakai</investigator_full_name>
    <investigator_title>Director, Neurosurgery</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

